DVAX
Dynavax Technologies Corp
Price:  
12.96 
USD
Volume:  
1,379,590.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX EV/EBITDA

-104.4%
Upside

As of 2024-12-15, the EV/EBITDA ratio of Dynavax Technologies Corp (DVAX) is 1,114.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DVAX's latest enterprise value is 1,807.82 mil USD. DVAX's TTM EBITDA according to its financial statements is 1.62 mil USD. Dividing these 2 quantities gives us the above DVAX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the low predictability of business.

Range Selected
Trailing P/E multiples 15.9x - 17.4x 16.6x
Forward P/E multiples 15.5x - 24.9x 20.2x
Fair Price (0.60) - (0.49) (0.57)
Upside -104.6% - -103.7% -104.4%
12.96 USD
Stock Price
(0.57) USD
Fair Price

DVAX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-13 1,114.56
2024-12-12 1,116.99
2024-12-11 1,110.51
2024-12-10 1,105.65
2024-12-09 1,104.84
2024-12-06 1,105.65
2024-12-05 1,104.03
2024-12-04 1,108.89
2024-12-03 1,100.79
2024-12-02 1,121.05
2024-11-29 1,106.46
2024-11-27 1,110.51
2024-11-26 1,090.25
2024-11-25 1,076.47
2024-11-22 1,070.80
2024-11-21 1,065.94
2024-11-20 1,050.54
2024-11-19 1,037.57
2024-11-18 1,011.64
2024-11-15 1,053.78
2024-11-14 1,149.41
2024-11-13 1,159.95
2024-11-12 1,158.33
2024-11-11 1,171.29
2024-11-08 1,118.61
2024-11-07 1,038.38
2024-11-06 1,060.26
2024-11-05 1,037.57
2024-11-04 1,019.74
2024-11-01 1,018.93
2024-10-31 1,024.61
2024-10-30 1,041.63
2024-10-29 1,021.36
2024-10-28 987.33
2024-10-25 932.22
2024-10-24 937.08
2024-10-23 945.19
2024-10-22 954.91
2024-10-21 954.10
2024-10-18 951.67
2024-10-17 949.24
2024-10-16 958.15
2024-10-15 936.27
2024-10-14 911.96
2024-10-11 909.53
2024-10-10 897.37
2024-10-09 922.49
2024-10-08 925.74
2024-10-07 937.08
2024-10-04 957.34